Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Underestimated role of MRI in EAU guidelines on prostate cancer.

Scialpi M, Piscioli I, D'Andrea A.

Magn Reson Imaging. 2014 May;32(4):402-3. doi: 10.1016/j.mri.2014.01.002. Epub 2014 Jan 10. No abstract available.

PMID:
24559864
2.

Early detection of prostate cancer: European Association of Urology recommendation.

Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, Wirth M, Mottet N; European Association of Urology.

Eur Urol. 2013 Sep;64(3):347-54. doi: 10.1016/j.eururo.2013.06.051. Epub 2013 Jul 9. Review.

PMID:
23856038
3.

Contemporary approaches to prostate cancer management.

Schalken JA, Westcott G.

Future Oncol. 2015;11(20):2735-6. doi: 10.2217/fon.15.238. No abstract available.

4.

Introduction. Dilemmas in the field of prostate cancer detection and treatment.

Joniau S.

Acta Oncol. 2011 Jun;50 Suppl 1:24. doi: 10.3109/0284186X.2010.578378. No abstract available.

PMID:
21604937
5.

Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

[No authors listed]

Ann Intern Med. 2013 May 21;158(10):I-28. doi: 10.7326/0003-4819-158-10-201305210-00634. No abstract available.

PMID:
23567761
6.

Managing localized prostate cancer in the era of prostate-specific antigen screening.

Brooks JD.

Cancer. 2013 Nov 15;119(22):3906-9. doi: 10.1002/cncr.28301. Epub 2013 Sep 4. No abstract available.

7.

The perils of PSA screening.

Susman J.

J Fam Pract. 2011 Jun;60(6):319. No abstract available.

PMID:
21647466
8.

EAU guidelines on prostate cancer.

Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J, Zattoni F; European Association of Urology.

Eur Urol. 2005 Oct;48(4):546-51. Review.

PMID:
16046052
9.

Preventing prostate cancer overdiagnosis from becoming overtreatment.

Hayes J, Barry MJ.

Oncology (Williston Park). 2011 May;25(6):468, 471, 478. No abstract available.

10.

"The older, the wiser" in prostate cancer treatment choices?

Repetto L, Abbatecola AM, Paolisso G.

Ann Intern Med. 2013 May 21;158(10):772-3. doi: 10.7326/0003-4819-158-10-201305210-00013. No abstract available.

PMID:
23689767
11.

Benefits and pitfalls of prostate cancer screening: "no proof of benefit" does not equal "proof of no benefit".

Chen CP, Staggers FE, Roach M 3rd.

Oncology (Williston Park). 2011 May;25(6):466, 468. No abstract available.

12.

Prostate cancer screening; is this a teachable moment?

Brawley OW.

J Natl Cancer Inst. 2009 Oct 7;101(19):1295-7. doi: 10.1093/jnci/djp310. Epub 2009 Aug 31. No abstract available.

PMID:
19720970
13.

Screening for prostate cancer remains controversial.

Stark JR, Mucci L, Rothman KJ, Adami HO.

BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601. No abstract available.

PMID:
19778971
14.

Detecting and treating prostate cancer: a surgeon's perspective.

Buchan NC.

N Z Med J. 2012 Apr 20;125(1353):6-8. No abstract available.

PMID:
22522266
15.

The new data on prostate cancer screening: what should we do now?

Gilligan T.

Cleve Clin J Med. 2009 Aug;76(8):446-8. doi: 10.3949/ccjm.76a.09079. No abstract available.

PMID:
19652037
16.

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F; European Association of Urology.

Eur Urol. 2011 Jan;59(1):61-71. doi: 10.1016/j.eururo.2010.10.039. Epub 2010 Oct 28.

PMID:
21056534
17.

Prostate-specific antigen screening for prostate cancer in older men in the United States of America.

Black A, Berg CD.

Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.

18.

Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Belpomme D, Irigaray P.

J Natl Cancer Inst. 2010 Apr 7;102(7):506-7. doi: 10.1093/jnci/djq045. Epub 2010 Feb 26. No abstract available.

PMID:
20190186
19.

Prostate cancer early detection. Clinical practice guidelines in oncology.

National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 May;2(3):190-207.

PMID:
19795604
20.

Perspective on...the new PSA screening recommendations.

Marsland T, Arena F, Yeilding A, Glodé M, Ellis L, Yu J, Henderson C, Wagman L, Piver S, Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W.

Oncology (Williston Park). 2011 Nov 15;25(12):1183, 1187-8, 1190. No abstract available.

Supplemental Content

Support Center